Phage Consultants

Phage Consultants

Gdańsk, Poland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $800K

Overview

Phage Consultants is a specialized service provider addressing the critical but niche problem of bacteriophage contamination in industrial bioprocesses. The company offers a comprehensive suite of services including facility audits, cell bank testing, phage production, characterization, and personnel training, primarily serving contract manufacturing organizations (CMOs) and biotechnology companies. With a strong reputation evidenced by client testimonials from firms like Aldevron and MetGen, it has established itself as a leading global consultant in phage contamination control. The business model is based on fee-for-service contracts and consulting, positioning it as a crucial partner for biomanufacturing security.

Infectious DiseaseMicrobiome

Technology Platform

Integrated suite of methodologies for bacteriophage detection, characterization, production, and bioprocess consultancy to prevent and mitigate phage contamination in industrial fermentation.

Funding History

2
Total raised:$800K
Grant$300K
Seed$500K

Opportunities

Growth is driven by the expansion of high-value bacterial fermentation for mRNA therapeutics, plasmid DNA, and sustainable chemicals, where contamination costs are extreme.
The emerging therapeutic phage therapy field also presents a potential new client segment for characterization and production services.

Risk Factors

The business is niche and dependent on the scale of the bacterial fermentation industry.
It faces key person risk centered on its founder and potential future competition from larger CROs expanding their service portfolios.

Competitive Landscape

Phage Consultants operates in a highly specialized niche with few, if any, direct competitors offering the same depth of focused expertise. Indirect competition may come from general microbiology testing labs or in-house teams at large biomanufacturers, but the company's established reputation and proven track record provide a strong competitive advantage.